Douglas P Dyer

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Science (New York, N.Y.)

Science signaling

Science advances

International journal of experimental pathology

University of Glasgow

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Glasgow Jan 1o 2015

United Kingdom

Postdoctoral Researcher :: Institute of Infection, Immunity and Inflammation

Publications

Tara E Sutherland, Douglas P Dyer, Judith E Allen
The extracellular matrix and the immune system: A mutually dependent relationship. Science (New York, N.Y.) 379 (6633) (2023)
Tara E Sutherland, Douglas P Dyer, Judith E Allen
The extracellular matrix and the immune system: A mutually dependent relationship. Science (New York, N.Y.) 379 (6633) (2023)
Tara E Sutherland, Douglas P Dyer, Judith E Allen
The extracellular matrix and the immune system: A mutually dependent relationship. Science (New York, N.Y.) 379 (6633) (2023)
Tara E Sutherland, Douglas P Dyer, Judith E Allen
The extracellular matrix and the immune system: A mutually dependent relationship. Science (New York, N.Y.) 379 (6633) (2023)
Amanda J L Ridley, Yaqing Ou, Richard Karlsson, Nabina Pun, Holly L Birchenough, Iashia Z Mulholland, Mary L Birch, Andrew S MacDonald, Thomas A Jowitt, Craig Lawless, Rebecca L Miller, Douglas P Dyer
Chemokines form complex signals during inflammation and disease that can be decoded by extracellular matrix proteoglycans. Science signaling 16 (810) (2023)
Tara E Sutherland, Douglas P Dyer, Judith E Allen
The extracellular matrix and the immune system: A mutually dependent relationship. Science (New York, N.Y.) 379 (6633) (2023)
Tara E Sutherland, Douglas P Dyer, Judith E Allen
The extracellular matrix and the immune system: A mutually dependent relationship. Science (New York, N.Y.) 379 (6633) (2023)
Anna L Gray, Nabina Pun, Amanda J L Ridley, Douglas P Dyer
Role of extracellular matrix proteoglycans in immune cell recruitment. International journal of experimental pathology 103 (2) (2022)
Richard Karlsson, Pradeep Chopra, Apoorva Joshi, Zhang Yang, Sergey Y Vakhrushev, Thomas Mandel Clausen, Chelsea D Painter, Gergo Peter Szekeres, Yen-Hsi Chen, Daniel R Sandoval, Lars Hansen, Jeffrey D Esko, Kevin Pagel, Douglas P Dyer, Jeremy E Turnbull, Henrik Clausen, Geert-Jan Boons, Rebecca L Miller
Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates. Science advances 7 (52) (2021)
Urszula M Cytlak, Douglas P Dyer, Jamie Honeychurch, Kaye J Williams, Mark A Travis, Timothy M Illidge
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nature reviews. Immunology (2021)
Douglas P Dyer
Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment. Immunology 160 (4) (2020)
Martin Gustavsson, Douglas P Dyer, Chunxia Zhao, Tracy M Handel
Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding. Science signaling 12 (598) (2019)
Douglas P Dyer, Elisa Migliorini, Catherina L Salanga, Dhruv Thakar, Tracy M Handel, Ralf P Richter
Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization. Open biology 7 (1) (2017)

Douglas P Dyer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Douglas P Dyer